The LifeValve Central Venous Catheter is indicated for patient therapy requiring acute or long-term (chronic) central venous access for the infusion of medications, parenteral solutions, parenteral nutrition solutions, or blood products, and for the withdrawal of blood samples.

Device Description

The LifeValve Central Venous Catheter includes a catheter and introduction components. The catheter is a percutaneous central venous catheter that incorporates a bidirectional valve assembly at the distal tip. The catheter is comprised of radiopaque silicone tubing, a molded radiopaque silicone tip with radiopaque marker band and a polvester implant cuff. It utilizes a luer lock connector and catheter Snap-Lock™ for proximal fittings. The catheter is equipped with a stylet stiffener. Each product is packaged in a sterile tray with 8 French introducer components. The family of LifeValve products includes externally communicating central venous catheters in two overall lengths, 50 and 65 cm.

AI/ML Overview

The provided text describes a medical device, the "LifeValve Central Venous Catheter," and its 510(k) submission for regulatory clearance. However, the text does not contain any information about acceptance criteria or a study proving the device meets specific performance metrics.

The document is a 510(k) summary and the FDA's letter of substantial equivalence. These documents focus on demonstrating that a new device is "substantially equivalent" to an already legally marketed predicate device, rather than providing detailed performance study results against specific acceptance criteria.

Therefore, I cannot fulfill your request for the tables and study details based on the provided input. The document mentions:

Device Description: It describes the physical characteristics and components of the LifeValve Central Venous Catheter.
Intended Use: It states the medical applications for which the catheter is designed.
Substantial Equivalence Comparison: It asserts that the LifeValve catheter is "identical in intended use and fundamental scientific technology" and "substantially similar in configuration, dimensions, and materials" to a predicate device (Strato Medical Single Lumen Valved Catheter, K924851). It also states that "Minor configurational, dimensional, and material changes have improved device performance" and were "evaluated through risk analysis and qualified through design verification testing and biomaterial safety evaluations following established Design Control procedures."

Missing Information:

The critical information you requested, such as specific acceptance criteria, detailed study designs, sample sizes for test/training sets, data provenance, ground truth establishment, expert qualifications, adjudication methods, or MRMC study results, is not present in the provided 510(k) summary and FDA letter. These types of detailed performance data are usually found in the full 510(k) submission or separate technical reports, not typically in the summary made publicly available.

Summary

{0}------------------------------------------------

Page 3 of 18

510(K) SUMMARY [AS REQUIRED BY 21 CFR 807.92(C)] 3

Submitter's Name / Contact Person

Manufacturer Horizon Medical Products, Inc. One Horizon Way Manchester, Georgia 31816

Contact Scott Moeller Director of Quality Assurance and Regulatory Affairs

General Information

Trade Name	LifeValve Central Venous Catheter
Common Name	Central venous catheter
Classification Name	Percutaneous, implanted, long-term intravascular catheter
	Classification Number:	21 CFR §880.5970
	Classification Panel:	General Hospital
	Product Code:	LJS
Equivalent Device	Product	Manufacturer	510(k) #
	Single Lumen Valved Catheter	Strato Medical Corp	K924851

Device Description

Intended Use

The LifeValve Central Venous Catheter is indicated for patient therapy requiring acute or longterm (chronic) central venous access for the infusion of medications, parenteral solutions, parenteral nutrition solutions, or blood products, and for the withdrawal of blood samples.

Substantial Equivalence Comparison

The LifeValve Central Venous Catheter and the predicate Strato Medical Single Lumen Valved Catheter are identical in intended use and fundamental scientific technology. The two devices are substantially similar in configuration, dimensions, and materials. Minor configurational, dimensional, and material changes have improved device performance. The design changes were evaluated through risk analysis and qualified through design verification testing and biomaterial safety evaluations following established Design Control procedures. The changes raise no new questions of safety or effectiveness.

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with three stripes forming its body and wings. The eagle is encircled by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" in a circular arrangement. The text is in all capital letters and is evenly spaced around the circle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 2 2003

Mr. Scott Moeller Director, Quality Assurance & Regulatory Affairs Horizon /medical Products, Incorporated 1 Horizon Way Manchester, Georgia 31816

Re: K031718

Trade/Device Name: LieValve Central Venous Catheter Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, Implanted, Long-term Intravascular Catheter Regulatory Class: II Product Code: LJS Dated: June 2, 2003 Received: June 4, 2003

Dear Mr. Moeller:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{2}------------------------------------------------

Page 2 - Mr. Moeller

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

Surar Punre

Susan Runner, DDS, MA Interim Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Attachments

Page 1 of 1

INDICATIONS FOR USE STATEMENT

510(k) Number (if known): K 631718

Device Name: LifeValve Central Venous Catheter

Indications for Use:

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Patuca Cuccurite

on of Anesthesiology. General Hospital Infection Control Der

510(k) Number: K031718

Regulation Number and Section

§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.

(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”